DK472182A - Fremgangsmaade til fremstilling af et praeparat til behandling af urinvejsinfektioner - Google Patents

Fremgangsmaade til fremstilling af et praeparat til behandling af urinvejsinfektioner Download PDF

Info

Publication number
DK472182A
DK472182A DK472182A DK472182A DK472182A DK 472182 A DK472182 A DK 472182A DK 472182 A DK472182 A DK 472182A DK 472182 A DK472182 A DK 472182A DK 472182 A DK472182 A DK 472182A
Authority
DK
Denmark
Prior art keywords
preparation
infections
procedure
urinal
treating
Prior art date
Application number
DK472182A
Other languages
English (en)
Inventor
William L Davies
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of DK472182A publication Critical patent/DK472182A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK472182A 1981-10-26 1982-10-25 Fremgangsmaade til fremstilling af et praeparat til behandling af urinvejsinfektioner DK472182A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/314,656 US4370313A (en) 1981-10-26 1981-10-26 Nitrofurantoin dosage form

Publications (1)

Publication Number Publication Date
DK472182A true DK472182A (da) 1983-04-27

Family

ID=23220880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK472182A DK472182A (da) 1981-10-26 1982-10-25 Fremgangsmaade til fremstilling af et praeparat til behandling af urinvejsinfektioner

Country Status (18)

Country Link
US (1) US4370313A (da)
EP (1) EP0078079B1 (da)
JP (1) JPS5883618A (da)
AT (1) AT387142B (da)
AU (1) AU557553B2 (da)
CA (1) CA1181695A (da)
DE (1) DE3276522D1 (da)
DK (1) DK472182A (da)
ES (1) ES516815A0 (da)
FI (1) FI823624L (da)
GR (1) GR77686B (da)
IE (1) IE54083B1 (da)
IL (1) IL66961A (da)
NO (1) NO157805C (da)
NZ (1) NZ202140A (da)
PH (1) PH17286A (da)
PT (1) PT75731B (da)
ZA (1) ZA827457B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US5560909A (en) * 1986-06-03 1996-10-01 Dowelanco Insecticidal compositions and process for preparation thereof
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US4938966A (en) * 1988-11-30 1990-07-03 Riker Laboratories, Inc. Controlled release flecainide acetate formulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
BR0313745A (pt) * 2002-08-23 2005-07-12 Ranbaxy Lab Ltd Apresentação farmacêutica de liberação controlada de nitrofurantoina e processo para sua preparação
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
CN102695554A (zh) * 2009-11-08 2012-09-26 梅达雷公司 用于形成空心纤维和空心纤维束的方法
CN108553443B (zh) * 2018-04-24 2020-09-01 江苏四环生物制药有限公司 一种呋喃妥因肠溶片的制备方法
IT201900000897A1 (it) * 2019-01-22 2020-07-22 Phf S A Formulazione a rilascio prolungato a permanenza gastrica a base di nitrofurantoina
CN116172969A (zh) * 2023-02-13 2023-05-30 山西太原药业有限公司 一种肠溶包衣、呋喃妥因肠溶制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE644759C (de) * 1932-11-23 1937-05-12 I G Farbenindustrie Akt Ges Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen
BE593353A (da) * 1959-02-18
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
DE1931910B2 (de) * 1969-06-24 1974-11-28 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication

Also Published As

Publication number Publication date
CA1181695A (en) 1985-01-29
JPS5883618A (ja) 1983-05-19
IE54083B1 (en) 1989-06-07
EP0078079A2 (en) 1983-05-04
JPS6241646B2 (da) 1987-09-03
ES8400871A1 (es) 1983-12-01
EP0078079B1 (en) 1987-06-10
NO823534L (no) 1983-04-27
GR77686B (da) 1984-09-25
NO157805C (no) 1988-05-25
PT75731A (en) 1982-11-01
IL66961A (en) 1986-02-28
AU557553B2 (en) 1986-12-24
ES516815A0 (es) 1983-12-01
FI823624A0 (fi) 1982-10-25
NO157805B (no) 1988-02-15
NZ202140A (en) 1985-12-13
DE3276522D1 (en) 1987-07-16
ZA827457B (en) 1984-05-30
EP0078079A3 (en) 1983-06-29
US4370313A (en) 1983-01-25
IL66961A0 (en) 1983-02-23
FI823624L (fi) 1983-04-27
PT75731B (en) 1985-06-28
IE822454L (en) 1983-04-26
AT387142B (de) 1988-12-12
PH17286A (en) 1984-07-06
AU8965182A (en) 1983-05-05
ATA390382A (de) 1988-05-15

Similar Documents

Publication Publication Date Title
DK151341C (da) Analogifremgangsmaade til fremstilling af d-phenylalanyl-l-prolyl-l-argininaldehydsulfat
DK149949C (da) Analogifremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK112582A (da) Fremgangsmaade til fremstilling af triazolonderivater
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK260682A (da) Fremgangsmaade til fremstilling af partikelformige geler
DK570482A (da) Fremgangsmaade til fremstilling af antiinflammatorisk oftalmisk oploesning
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK84082A (da) Fremgangsmaade til fremstilling af pg12-derivater
DK472182A (da) Fremgangsmaade til fremstilling af et praeparat til behandling af urinvejsinfektioner
DK354382A (da) Fremgangsmaade til fremstilling af aminopyridazinforbindelser
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK161482A (da) Fremgangsmaade til fremstilling af et analgetisk praeparat
DK155791C (da) Fremgangsmaade til fremstilling af cementklinker
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK127482A (da) Fremgangsmaade til fremstilling af dipeptidforbindelser
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK150986C (da) Fremgangsmaade til fremstilling af azopigmentpraeparater
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK158442C (da) Fremgangsmaade til fremstilling af et praeparat til behandling af negleinfektioner
DK309282A (da) Fremgangsmaade til fremstilling af et analgetisk praeparat
DK155726C (da) Fremgangsmaade til fremstilling af cementklinker
DK392082A (da) Fremgangsmaade til fremstilling af antibiotiket nosiheptid

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment